Saltar al contenido
Merck

Currently available drugs for the treatment of obesity: Sibutramine and orlistat.

Mini reviews in medicinal chemistry (2007-02-03)
J-P Chaput, S St-Pierre, A Tremblay
RESUMEN

The currently available drugs for long-term treatment of obesity are sibutramine and orlistat. They have been shown to be able to induce significant weight loss, with important co-morbidity reduction, allowing the maintenance of reduced body weight for at least 1-2 years. Cardiostimulating and gastrointestinal adverse effects are however not negligible.

MATERIALES
Número de producto
Marca
Descripción del producto

Sigma-Aldrich
Orlistat, ≥98%, solid
En este momento no podemos mostrarle ni los precios ni la disponibilidad
USP
Orlistat, United States Pharmacopeia (USP) Reference Standard
En este momento no podemos mostrarle ni los precios ni la disponibilidad